Lv41
540 积分 2022-11-24 加入
Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications
1小时前
待确认
Ziftomenib: First Approval
3个月前
已完结
Menin Inhibitors: A New Era of Targeted Therapies in Acute Myeloid Leukemia
3个月前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
3个月前
已完结
Next generation epigenetic modulators to target myeloid neoplasms
3个月前
已完结
Revumenib for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation
3个月前
已完结
Revumenib: First Approval
3个月前
已完结
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
3个月前
已完结
MEN1 mutations mediate clinical resistance to menin inhibition
3个月前
已完结
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
3个月前
已完结
皖公网安备34019202002308
